Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy

doi:10.3748/wjg.v19.i39.6515

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 39

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7439)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

521

HTML

3959

Figures (1-1)

256

Tables (1-4)

239

Sum=4975

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1180

Download

1284

Sum=2464

Oct 21, 2013 (publication date) through Dec 20, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 21, 2013; 19(39): 6515-6522
Published online Oct 21, 2013. doi: 10.3748/wjg.v19.i39.6515

Open in New Tab Full Size Figure Download Figure

Figure 1 Risk of hepatocellular carcinoma in the next 3 years by risk scores. Results adopted from Wong et al[22]. HCC: Hepatocellular carcinoma.

Citation: Wong GLH, Wong VWS. Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy. World J Gastroenterol 2013; 19(39): 6515-6522
URL: https://www.wjgnet.com/1007-9327/full/v19/i39/6515.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i39.6515